相关实验视频

Updated: Jan 9, 2026

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

Published on: January 21, 2020

新型基于醇的醇胺2,3-二氧化酶-1 (IDO1) 抑制剂:设计,合成和抗抑郁药物评估

Juan Zhang¹, Wen-Jing Gao², Yu-Xi Zheng¹

¹School of Biological Science and Technology, University of Jinan, Jinan 250022, China.

Bioorganic & medicinal chemistry

|December 5, 2025

概括

研究人员开发了新的以醇为基础的化合物,针对潜在的抗抑郁药物治疗的醇胺2,3-二氧化原酶-1 (IDO1). 这些化合物显示出更好的疗效和药理动力学特性,为治疗抑郁症提供了一个有前途的新途径.

科学领域:

药用化学医学化学
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

印度醇胺2,3-二氧化原酶-1 (IDO1) 是开发新型抗抑郁药物的关键目标.
现有的IDO1抑制剂需要进行结构优化,以提高治疗潜力.

研究的目的:

为了进行基于杆跳跃的结构优化,对本齐米达衍生的IDO1抑制剂.
为了识别具有改进的IDO1抑制活性和抗抑郁药物潜力的新型基于醇的化合物.

主要方法:

已知IDO1抑制剂的架构跳跃和结构优化.
在体外测试以确定IDO1抑制活性 (IC50值).
在体外和体外的药理动力学研究.
评估LPS刺激的微质细胞中的抗炎活性.
在小鼠模型中评估类似抗抑郁药的行为.

主要成果:

合成了基于醇的新型IDO1抑制剂,其中9f和10f化合物表现出强烈的活性 (IC50值分别为9.18 ± 0.84 nM和6.57 ± 0.61 nM).
化合物10f在LPS刺激的BV-2微质细胞中表现出抗炎作用.
化合物9f和10f被证明增强了体外和体外的药物动力学特征.
这些化合物成功地在小鼠中拯救了LPS诱导的抑郁类行为.

结论:

基于indole的IDO1抑制剂代表了抗抑郁药物开发的有前途的化合物类.
化合物9f和10f作为进一步研究和优化的主要候选物.
针对IDO1为新型抗抑郁药疗法提供了可行的策略,具有潜在的抗炎功效.

关键词:

抗炎药物抗炎药物抗炎药物抗抑郁作用抗抑郁作用这是一种IDO1抑制剂.印度尔衍生品的印度尔衍生药物动力学概况药物动力学概况

更多相关视频

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

Synthesis of Indoxyl-glycosides for Detection of Glycosidase Activities

Synthesis of Indoxyl-glycosides for Detection of Glycosidase Activities

Published on: May 27, 2015

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...